Explore

Trendline Trendline
Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch

Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch

Mineralys Therapeutics Reports Financial Results and Prepares for Lorundrostat Launch
Trendline Trendline
AbCellera Initiates $200 Million Public Offering to Fund Research and Development

AbCellera Initiates $200 Million Public Offering to Fund Research and Development

AbCellera Initiates $200 Million Public Offering to Fund Research and Development
Trendline Trendline
Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development

Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development

Veradermics Reports Strong Financial Position and Progress in Hair Loss Treatment Development
Trendline Trendline
TG Therapeutics Reports Strong Q2 2026 Earnings with Increased Revenue Guidance

TG Therapeutics Reports Strong Q2 2026 Earnings with Increased Revenue Guidance

TG Therapeutics Reports Strong Q2 2026 Earnings with Increased Revenue Guidance
Trendline Trendline
Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials

Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials

Veru Inc. Advances Obesity Treatment with Novo Nordisk Partnership and Reports Q3 2026 Financials
Trendline Trendline
Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026

Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026

Axsome Therapeutics Reports Strong Financial Growth and New Product Launches in Q2 2026
Trendline Trendline
Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements

Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements

Aura Biosciences Reports Increased Net Loss in Q2 2026 Amid Clinical Advancements
Trendline Trendline
Marriott Reports Strong Q2 2026 Earnings, Driven by Global RevPAR Growth

Marriott Reports Strong Q2 2026 Earnings, Driven by Global RevPAR Growth

Marriott Reports Strong Q2 2026 Earnings, Driven by Global RevPAR Growth
Trendline Trendline
SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure

SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure

SION Stock Plummets 90% After Cystic Fibrosis Drug Trial Failure
Trendline Trendline
Himalaya Shipping Reports Strong Q2 2026 Earnings Amid Higher Charter Rates

Himalaya Shipping Reports Strong Q2 2026 Earnings Amid Higher Charter Rates

Himalaya Shipping Reports Strong Q2 2026 Earnings Amid Higher Charter Rates
Trendline Trendline
Rocket Lab Reports Record Revenue in Q2 2026 Amidst Stock Decline

Rocket Lab Reports Record Revenue in Q2 2026 Amidst Stock Decline

Rocket Lab Reports Record Revenue in Q2 2026 Amidst Stock Decline
Trendline Trendline
Omeros Corporation to Release Q2 Financial Results Amid Strategic Developments

Omeros Corporation to Release Q2 Financial Results Amid Strategic Developments

Omeros Corporation to Release Q2 Financial Results Amid Strategic Developments